During the past decade, Howard University Center for Sickle Cell Disease conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Howard University Center for Sickle Cell Disease" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Howard University Center for Sickle Cell Disease" are "Sickle Cell Disease" (3 trials), "Anemia, Sickle Cell" (1 trials), "Pain Crisis" (1 trials), "Sickle Cell Anemia" (1 trials) and "Sickle Cell Disorders" (1 trials). Many other conditions were trialed in "Howard University Center for Sickle Cell Disease" in a lesser frequency.

Most popular intervention types in "Howard University Center for Sickle Cell Disease" are "Drug" (3 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Rivipansel" (2 trials), "IW-1701" (1 trials), "Red Blood Cell" (1 trials) and "Standard of care" (1 trials). Other intervention names were less common.

The vast majority of trials in "Howard University Center for Sickle Cell Disease" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Howard University Center for Sickle Cell Disease". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Howard University Center for Sickle Cell Disease, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Howard University Center for Sickle Cell Disease, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".